Literature DB >> 25627419

Low molybdenum state induced by tungsten as a model of molybdenum deficiency in rats.

Munehiro Yoshida1, Mikihito Nakagawa, Ryota Hosomi, Toshimasa Nishiyama, Kenji Fukunaga.   

Abstract

Organ molybdenum (Mo) concentration and the activity of hepatic sulfite oxidase and xanthine oxidase were compared in tungsten-administered rats as well as rats fed with a low Mo diet to evaluate the use of tungsten-administered rats as a model of Mo deficiency. Twenty-four male 6-week-old Wistar rats were divided into four groups according to diet (AIN93G diet (control diet) or the control diet minus ammonium molybdate (low Mo diet)) and drinking water (deionized water or deionized water containing 200 μg/mL tungsten in the form of sodium tungstate). Mo content in the control and low Mo diets were 196 and 42 ng/g, respectively. Intake of the low Mo diet significantly reduced the Mo content of several organs and serum. Decrease in hepatic sulfite oxidase activity was also induced by the low Mo diet. The administration of tungsten induced marked decreases in organ Mo content and the activity of hepatic sulfite oxidase and xanthine oxidase. These decreases induced by tungsten administration were more pronounced than those induced by just a low Mo diet. Serum uric acid was also reduced by tungsten administration irrespective of Mo intake. Although a comparatively high accumulation of tungsten (3 to 9 μg/g) was observed in the kidneys and liver, adverse effects of tungsten accumulation on liver and kidney function were not observed in serum biochemical tests. These results indicate that tungsten-administered animals may be used as a model of Mo deficiency.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25627419     DOI: 10.1007/s12011-015-0239-1

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  2 in total

1.  Urinary tungsten and incident cardiovascular disease in the Strong Heart Study: An interaction with urinary molybdenum.

Authors:  Anne E Nigra; Barbara V Howard; Jason G Umans; Lyle Best; Kevin A Francesconi; Walter Goessler; Richard Devereux; Ana Navas-Acien
Journal:  Environ Res       Date:  2018-06-22       Impact factor: 6.498

2.  When Is a Rare Disease Not so Rare? Implications for Medical Nutrition Therapy.

Authors:  Jeffrey Bland
Journal:  Integr Med (Encinitas)       Date:  2016-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.